CD209 and neoplasm: Characteristic differentiation markers of moDCs, including CD14 [22], DC-SIGN [23], and group 1 CD1 family members [22], were compared on moDCs conditioned by different tumor cell lines (adenocarcinoma cell lines; MDA, HT29, HeLa, primer melanoma cell lines; WM278, WM983A, and metastatic melanoma cell lines; WM1617, WM983B).